MELBOURNE, July 22 (Reuters) - Australian cancer and cardiac care provider GenesisCare said on Friday a Chinese-led consortium has agreed to buy up to 74 percent of the group. No price tag was disclosed.
It said private equity firm KKR KKR.N has agreed to sell its 45 percent stake in the business to the consortium of Hong Kong-based China Resources Group and Macquarie Capital MQG.AX .